- AU$149.74m
- AU$106.76m
- AU$16.23m
Australia's Orthocell surges on sales approval in Singapore
Brief: Orthocell Submits Thailand Regulatory Application To Commence Sales Of Remplir
Brief: Orthocell Submits Canada Regulatory Application To Commence Sales Of Remplir
Australia's Orthocell climbs to 2-week high as co floats expansion plans
Brief: Orthocell Says Market Expansion Of Remplir Will Be Accelerated
Australian medicine co Orthocell hits record high on US FDA clearance
Brief: Orthocell Seeks Trading Halt
Australia's Orthocell hits more than 5-year high on Singapore expansion deal
Brief: Orthocell Says Appoints Exclusive Distributor In Singapore For Remplir
Australia's Orthocell falls most in more than 1-1/2 years on discounted placement
Brief: Orthocell Says A$17M Placement To Drive Further Growth
Brief: Orthocell Seeks Trading Halt
Orthocell hits highest since Dec 2021 on regulatory nod for sale in Singapore
Brief: Orthocell Announces Regulatory Approval To Commence Remplir Sales In Singapore
Brief: Orthocell Seeks Trading Halt
Australia's Orthocell hits over 3-week high on positive Q2 results
Brief: Orthocell Ltd Posts Revenue A$2.03M In Sept Quarter
Brief: Orthocell Says First Sales Of Striate Major New Market Of Canada
Brief: Orthocell's Application In Singapore Accepted For Review By HSA